Infusion
Nursing Notes
By Nufactor

Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Side Effects of IG Therapy: How to Prevent and Manage Them

11. September 2014 Cindi Berry (0)
By Cindy Berry, RN, BSN.

This week's IGL Blog is sponsored by NuFACTOR Speciality Pharmacy.

Immune Globulin (IG) therapy is used to treat many different diseases. Because the drug itself can have many side effects when administered, it is important for patients to understand what to do when facing side effects from therapy to ensure a treatment is well tolerated. [More]

IVIG and Epilepsy

29. July 2014 Elissa Ritt (0)
You may not think of epilepsy as a disease state that can be treated by intravenous immune globulin (IVIG). But, in this week’s blog we will discuss the subset of epilepsy patients whose disease may be caused by autoimmunity. And, it is theorized that these epilepsy patients, whose own antibodies are responsible for their disease, may benefit from IVIG therapy. [More]

Weaning IVIG Therapy for CIDP

15. July 2014 Michelle Greer (1)
Previously we began discussing how to wean patients with CIDP off IVIg therapy. In this week’s blog, we address common fears and questions. As well as when and how to implement a tapering plan. [More]

Managing IVIG Therapy for CIDP

1. July 2014 Jonathan S. Katz (0)
Many patients with chronic inflammatory demyelinating polyneuropathy (CIDP) are treated with intravenous immune globulin (IVIG). But, treatment plans can vary greatly and are influenced by a variety of factors. [More]

New Study Recruiting CIDP Patients

3. June 2014 Elissa Ritt (0)
A new study is being conducted to evaluate the efficacy, safety and tolerability of treating chronic inflammatory demyelinating polyneuropathy (CIDP) patients with subcutaneous immune globulin (SCIG). Could you be a candidate? [More]

Hematologic Malignancies (Blood Cancers)

20. May 2014 Cindi Berry (0)
Hematologic malignancies are a type of cancer that affects blood, bone marrow and lymph nodes.
Blood cancers affect the production and function of blood cells. Most of these cancers start in the bone marrow where blood is produced. [More]

Payers

IG & Coagulation Resources
Site of Care Savings

Support

Contact Us
Refer a Patient
Become a Patient

About Us

Mission & Vision
Core Values
Careers

Nufactor

Service Model
Accreditation
IgCP, IgCN, CSP

Nufactor, Inc. is the specialty pharmacy subsidiary of FFF Enterprises.

Nufactor Corporate
Headquarters
44900 Winchester Road
Temecula, CA 92590

(800) 323-6832

Home • Terms • Privacy Statement • • About Us • Careers
©2022 Nufactor